Why getgoodpeptides exists
“Good” sounds settled until a follow-up visit changes the story.
Ordinary outcomes
What draws me to these experiments is their unglamorous end: how fast a child grew, whether someone tolerated a meal, how much abdominal fat returned. Hormone chemistry can be beautiful, but those ordinary measurements make me more demanding about the word “improvement”.
The tesamorelin follow-up after treatment stopped gave that interest a focus. Fat reduction during treatment and its return afterwards are both findings worth knowing. I admire the decision to measure beyond the favorable moment. A name like getgoodpeptides invites a cheerful verdict; I prefer a verdict with the participants and the follow-up still attached.
That preference also makes room for praise. The sermorelin pediatric growth result is a real achievement in a defined condition. The albumin-binding design behind CJC-1295’s long hormone response is inventive. I become doubtful when those particular successes are stretched into broad adult wellness expectations.
This site and personal care
The essays at getgoodpeptides grew out of my interest in ipamorelin, CJC-1295, sermorelin and tesamorelin. No clinical care is available here: the site offers no consultations, prescriptions or products. Medical advice requires an assessment of the person seeking care; these essays cannot provide that assessment.
The questions a favorable result leaves alive are often the ones that interest me most. How much of the change persists? Does it matter in daily life? Who was missing from the trial? Those questions are a reason to read further, rather than grounds for dismissing every early experiment.
The reading list includes the studies, reviews and editorials discussed here. A correction to an outcome, compound or population would be especially welcome through editorial contact. A small factual error can change the entire judgment of whether something helped.